Life

Nordex FY20 Loss Widens, Sales Surge; Sees Growth In FY21; Confirms FY22 Goals

Opinion | The Johnson & Johnson Shot Was My Ticket Out of Hell

Some people are balking at the one-shot vaccine, but I was thrilled to get it.

By Michelle Goldberg

Opinion Columnist

Novo Nordisk : FDA Seeks Additional Data On Type 2 Diabetes Drug Semaglutide

Danish pharmaceutical company Novo Nordisk A/S (NVO) said Monday that the US Food and Drug Administration issued a Refusal to File letter covering the label expansion application for once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes which was filed on 20 January 2021.

In the letter, FDA has requested additional information including data relating to a proposed new manufacturing site.

Additional information needs to be included in the resubmission. But the company believes the already completed clinical trial program will be sufficient for approval of the label expansion application.

The company expects to resubmit the application to FDA during the second quarter of 2021.

Kayleigh McEnany: Biden must be asked ‘hard questions’ on border at first press conference

McEnany: Media must ask Biden ‘really hard questions’ at first presser

Former White House press secretary joins ‘Hannity’ to preview Thursday’s scheduled news conference

President Biden is set to hold his first formal press conference on Thursday, and former White House press secretary Kayleigh McEnany told “Hannity” that it’s imperative that he be pressed on the situation at the southern border. 

MCENANY: It’s incredible what the Biden White House is able to get away with … The press needs to ask these really hard questions of him, and I’m not just saying, you know, ‘What are your thoughts on the border? That’s not a sufficient checking-of-the-box question.

“They need to ask him, ‘You say you blame this on Trump. Explain to me specifically how this is Trump’s fault when, in fact, numbers came down when he took historic immigration action in 2019. And [now] they’ve gone up and they’re wearing Biden t-shirts, flying Biden flags and, on camera, citing that they’re coming here because of you. He needs to be confronted that directly and that specifically.”

CLICK HERE TO WATCH THE FULL INTERVIEW 

No. 1 Michigan rallies past No. 8 LSU to keep Big Ten afloat in men’s NCAA Tournament

Michigan is headed to the Sweet 16. 

The Wolverines, the No. 1 seed in the East Region, outlasted No. 8 seed LSU, 86-78, in a back-and-forth contest on Monday night in the second round of the NCAA tournament at Lucas Oil Stadium in Indianapolis.

Michigan's win salvaged some Big Ten pride after a disappointing men's tournament for the conference's teams. The Big Ten sent an NCAA-best nine teams to the Big Dance, with two No. 1 seeds and two No. 2 seeds. By the end of the night, the Wolverines could be the only Big Ten team left standing.

LSU jumped out to an early lead to start the game and played exceptional offense. But Michigan responded in kind. And it came up with key stops when it mattered the most.

Eli Brooks and Chaundee Brown each scored 21 points, making a combined eight 3-pointers. Hunter Dickinson scored 12 points and grabbed 11 rebounds. Franz Wagner was quiet in the first half — but scored nine points in the final five minutes, making Michigan's last four field goals.

Mass shooting in Boulder weighs heavily on Colorado men’s coach Tad Boyle, players

Shortly before Colorado’s second-round NCAA men’s basketball tournament game against Florida State on Monday, coach Tad Boyle began to see alerts on his phone about the mass shooting at a Boulder grocery store that killed 10 people, including a police officer. 

When the Buffaloes tipped off, details were still murky, and Boyle decided against addressing it with the team, though he assumed many of them were getting messages from back home and knew as much as he did. 

After Colorado’s 71-53 season-ending loss, Boyle said the events had weighed on his mind throughout the night, and that his heart went out to the families who lost loved ones in the tragedy. 

Nordex FY20 Loss Widens, Sales Surge; Sees Growth In FY21; Confirms FY22 Goals

German wind turbine manufacturer Nordex Group (NRDXF.PK) reported Tuesday that its fiscal 2020 consolidated net loss widened to 129.7 million euros from 72.6 million euros last year.

EBITDA fell 24.1 percent to 94.0 million euros from 123.8 million euros a year ago. At 2 percent, the company’s EBITDA margin reached the expected level but was well below the previous year’s figure of 3.8 percent.

Consolidated sales increased sharply by 41.6 percent to 4.65 billion euros from 3.28 billion euros a year ago.

The company increased its production to around 6 GW in the year. The order book for new wind turbines was 5.3 billion euros, slightly down from 5.5 billion euros last year.

Looking ahead for fiscal 2021, Nordex anticipates a further rise in sales and operating profit. Consolidated sales are expected to reach 4.7 billion euros to 5.2 billion euros, with sales likely to be relatively evenly distributed across the year.

The Company is aiming for an EBITDA margin in a range of 4.0 to 5.5 percent. This is likely to increase gradually during the year as low-margin projects come to an end and the more profitable Delta4000 platform gains a greater share of projects.

Nordex currently expects the impact of the Covid-19 pandemic on its business to be reduced from the second quarter onwards.

Further ahead, Nordex said it is on the right track and confirmed its strategic targets for 2022 of sales of around 5 billion euros and EBITDA margin of 8 percent.